 | • レポートコード：D005-00370 • 出版社/出版日：GlobalInfoResearch / 2020年5月29日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、108ページ • 納品方法：Eメール • 産業分類：医療・製薬 |
| Single User | ￥515,040 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥772,560 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,030,080 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査レポートでは、腸疾患検査＆治療の世界市場を広く調査・分析し、今後の市場展望をまとめております。腸疾患検査＆治療の種類別市場規模（細菌性疾患、ウイルス性疾患、寄生虫性疾患）、用途別市場規模（病院、研究）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、企業別販売量と市場シェア、販売チャネルなどの情報を掲載しています。 ・市場概要 ・企業情報（販売量、市場シェア、製品概要、SWOT分析）：Abbott、Quest Diagnostics、bioMérieux、GlaxoSmithKline、Bio-Rad、Becton Dickinson、Bayer Pharma、Sanofi、Trinity Biotech ・地域別グローバル市場分析 2015年-2020年 ・腸疾患検査＆治療の北米市場（アメリカ、カナダ、メキシコ） ・腸疾患検査＆治療のヨーロッパ市場（ドイツ、イギリス、フランス、ロシア、イタリア） ・腸疾患検査＆治療のアジア市場（中国、日本、韓国、インド、東南アジア、オーストラリア） ・腸疾患検査＆治療の南米市場（ブラジル、アルゼンチン） ・腸疾患検査＆治療の中東・アフリカ市場（サウジアラビア、トルコ、エジプト、南アフリカ） ・種類別分析：細菌性疾患、ウイルス性疾患、寄生虫性疾患 ・用途別分析：病院、研究 ・地域別市場規模予測 2021年-2025年 ・販売チャネル、流通業者、代理店 ・調査の結果・結論 |
Market Overview
The global Enteric Disease Testing and Therapeutic market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of 1.4% in the forecast period of 2020 to 2025 and will expected to reach USD 3273.4 million by 2025, from USD 3101.6 million in 2019.
The Enteric Disease Testing and Therapeutic market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
Market segmentation
Enteric Disease Testing and Therapeutic market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
By Type, Enteric Disease Testing and Therapeutic market has been segmented into:
Bacterial disease
Viral disease
Parasitic diseases
By Application, Enteric Disease Testing and Therapeutic has been segmented into:
Hospital
Research
Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Enteric Disease Testing and Therapeutic market presented in the report. This section sheds light on the sales growth of different regional and country-level Enteric Disease Testing and Therapeutic markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Enteric Disease Testing and Therapeutic market.
The report offers in-depth assessment of the growth and other aspects of the Enteric Disease Testing and Therapeutic market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Australia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Competitive Landscape and Enteric Disease Testing and Therapeutic Market Share Analysis
Enteric Disease Testing and Therapeutic competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Enteric Disease Testing and Therapeutic sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Enteric Disease Testing and Therapeutic sales, revenue and market share for each player covered in this report.
The major players covered in Enteric Disease Testing and Therapeutic are:
Abbott
Quest Diagnostics
bioMérieux
GlaxoSmithKline
Bio-Rad
Becton Dickinson
Bayer Pharma
Sanofi
Trinity Biotech
Table of Contents
1 Enteric Disease Testing and Therapeutic Market Overview
1.1 Product Overview and Scope of Enteric Disease Testing and Therapeutic
1.2 Classification of Enteric Disease Testing and Therapeutic by Type
1.2.1 Global Enteric Disease Testing and Therapeutic Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Global Enteric Disease Testing and Therapeutic Revenue Market Share by Type in 2019
1.2.3 Bacterial disease
1.2.4 Viral disease
1.2.5 Parasitic diseases
1.3 Global Enteric Disease Testing and Therapeutic Market by Application
1.3.1 Overview: Global Enteric Disease Testing and Therapeutic Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Hospital
1.3.3 Research
1.4 Global Enteric Disease Testing and Therapeutic Market by Regions
1.4.1 Global Enteric Disease Testing and Therapeutic Market Size by Regions: 2015 VS 2019 VS 2025
1.4.2 Global Market Size of Enteric Disease Testing and Therapeutic (2015-2025)
1.4.3 North America (USA, Canada and Mexico) Enteric Disease Testing and Therapeutic Status and Prospect (2015-2025)
1.4.4 Europe (Germany, France, UK, Russia and Italy) Enteric Disease Testing and Therapeutic Status and Prospect (2015-2025)
1.4.5 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Enteric Disease Testing and Therapeutic Status and Prospect (2015-2025)
1.4.6 South America (Brazil, Argentina, Colombia) Enteric Disease Testing and Therapeutic Status and Prospect (2015-2025)
1.4.7 Middle East & Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Enteric Disease Testing and Therapeutic Status and Prospect (2015-2025)
2 Company Profiles
2.1 Abbott
2.1.1 Abbott Details
2.1.2 Abbott Major Business and Total Revenue (Financial Highlights) Analysis
2.1.3 Abbott SWOT Analysis
2.1.4 Abbott Product and Services
2.1.5 Abbott Enteric Disease Testing and Therapeutic Revenue, Gross Margin and Market Share (2018-2019)
2.2 Quest Diagnostics
2.2.1 Quest Diagnostics Details
2.2.2 Quest Diagnostics Major Business and Total Revenue (Financial Highlights) Analysis
2.2.3 Quest Diagnostics SWOT Analysis
2.2.4 Quest Diagnostics Product and Services
2.2.5 Quest Diagnostics Enteric Disease Testing and Therapeutic Revenue, Gross Margin and Market Share (2018-2019)
2.3 bioMérieux
2.3.1 bioMérieux Details
2.3.2 bioMérieux Major Business and Total Revenue (Financial Highlights) Analysis
2.3.3 bioMérieux SWOT Analysis
2.3.4 bioMérieux Product and Services
2.3.5 bioMérieux Enteric Disease Testing and Therapeutic Revenue, Gross Margin and Market Share (2018-2019)
2.4 GlaxoSmithKline
2.4.1 GlaxoSmithKline Details
2.4.2 GlaxoSmithKline Major Business and Total Revenue (Financial Highlights) Analysis
2.4.3 GlaxoSmithKline SWOT Analysis
2.4.4 GlaxoSmithKline Product and Services
2.4.5 GlaxoSmithKline Enteric Disease Testing and Therapeutic Revenue, Gross Margin and Market Share (2018-2019)
2.5 Bio-Rad
2.5.1 Bio-Rad Details
2.5.2 Bio-Rad Major Business and Total Revenue (Financial Highlights) Analysis
2.5.3 Bio-Rad SWOT Analysis
2.5.4 Bio-Rad Product and Services
2.5.5 Bio-Rad Enteric Disease Testing and Therapeutic Revenue, Gross Margin and Market Share (2018-2019)
2.6 Becton Dickinson
2.6.1 Becton Dickinson Details
2.6.2 Becton Dickinson Major Business and Total Revenue (Financial Highlights) Analysis
2.6.3 Becton Dickinson SWOT Analysis
2.6.4 Becton Dickinson Product and Services
2.6.5 Becton Dickinson Enteric Disease Testing and Therapeutic Revenue, Gross Margin and Market Share (2018-2019)
2.7 Bayer Pharma
2.7.1 Bayer Pharma Details
2.7.2 Bayer Pharma Major Business and Total Revenue (Financial Highlights) Analysis
2.7.3 Bayer Pharma SWOT Analysis
2.7.4 Bayer Pharma Product and Services
2.7.5 Bayer Pharma Enteric Disease Testing and Therapeutic Revenue, Gross Margin and Market Share (2018-2019)
2.8 Sanofi
2.8.1 Sanofi Details
2.8.2 Sanofi Major Business and Total Revenue (Financial Highlights) Analysis
2.8.3 Sanofi SWOT Analysis
2.8.4 Sanofi Product and Services
2.8.5 Sanofi Enteric Disease Testing and Therapeutic Revenue, Gross Margin and Market Share (2018-2019)
2.9 Trinity Biotech
2.9.1 Trinity Biotech Details
2.9.2 Trinity Biotech Major Business and Total Revenue (Financial Highlights) Analysis
2.9.3 Trinity Biotech SWOT Analysis
2.9.4 Trinity Biotech Product and Services
2.9.5 Trinity Biotech Enteric Disease Testing and Therapeutic Revenue, Gross Margin and Market Share (2018-2019)
3 Market Competition, by Players
3.1 Global Enteric Disease Testing and Therapeutic Revenue and Share by Players (2015-2020)
3.2 Market Concentration Rate
3.2.1 Top 5 Enteric Disease Testing and Therapeutic Players Market Share
3.2.2 Top 10 Enteric Disease Testing and Therapeutic Players Market Share
3.3 Market Competition Trend
4 Market Size by Regions
4.1 Global Enteric Disease Testing and Therapeutic Revenue and Market Share by Regions
4.2 North America Enteric Disease Testing and Therapeutic Revenue and Growth Rate (2015-2020)
4.3 Europe Enteric Disease Testing and Therapeutic Revenue and Growth Rate (2015-2020)
4.4 Asia-Pacific Enteric Disease Testing and Therapeutic Revenue and Growth Rate (2015-2020)
4.5 South America Enteric Disease Testing and Therapeutic Revenue and Growth Rate (2015-2020)
4.6 Middle East & Africa Enteric Disease Testing and Therapeutic Revenue and Growth Rate (2015-2020)
5 North America Enteric Disease Testing and Therapeutic Revenue by Countries
5.1 North America Enteric Disease Testing and Therapeutic Revenue by Countries (2015-2020)
5.2 USA Enteric Disease Testing and Therapeutic Revenue and Growth Rate (2015-2020)
5.3 Canada Enteric Disease Testing and Therapeutic Revenue and Growth Rate (2015-2020)
5.4 Mexico Enteric Disease Testing and Therapeutic Revenue and Growth Rate (2015-2020)
6 Europe Enteric Disease Testing and Therapeutic Revenue by Countries
6.1 Europe Enteric Disease Testing and Therapeutic Revenue by Countries (2015-2020)
6.2 Germany Enteric Disease Testing and Therapeutic Revenue and Growth Rate (2015-2020)
6.3 UK Enteric Disease Testing and Therapeutic Revenue and Growth Rate (2015-2020)
6.4 France Enteric Disease Testing and Therapeutic Revenue and Growth Rate (2015-2020)
6.5 Russia Enteric Disease Testing and Therapeutic Revenue and Growth Rate (2015-2020)
6.6 Italy Enteric Disease Testing and Therapeutic Revenue and Growth Rate (2015-2020)
7 Asia-Pacific Enteric Disease Testing and Therapeutic Revenue by Countries
7.1 Asia-Pacific Enteric Disease Testing and Therapeutic Revenue by Countries (2015-2020)
7.2 China Enteric Disease Testing and Therapeutic Revenue and Growth Rate (2015-2020)
7.3 Japan Enteric Disease Testing and Therapeutic Revenue and Growth Rate (2015-2020)
7.4 Korea Enteric Disease Testing and Therapeutic Revenue and Growth Rate (2015-2020)
7.5 India Enteric Disease Testing and Therapeutic Revenue and Growth Rate (2015-2020)
7.6 Southeast Asia Enteric Disease Testing and Therapeutic Revenue and Growth Rate (2015-2020)
8 South America Enteric Disease Testing and Therapeutic Revenue by Countries
8.1 South America Enteric Disease Testing and Therapeutic Revenue by Countries (2015-2020)
8.2 Brazil Enteric Disease Testing and Therapeutic Revenue and Growth Rate (2015-2020)
8.3 Argentina Enteric Disease Testing and Therapeutic Revenue and Growth Rate (2015-2020)
9 Middle East & Africa Revenue Enteric Disease Testing and Therapeutic by Countries
9.1 Middle East & Africa Enteric Disease Testing and Therapeutic Revenue by Countries (2015-2020)
9.2 Saudi Arabia Enteric Disease Testing and Therapeutic Revenue and Growth Rate (2015-2020)
9.3 UAE Enteric Disease Testing and Therapeutic Revenue and Growth Rate (2015-2020)
9.4 Egypt Enteric Disease Testing and Therapeutic Revenue and Growth Rate (2015-2020)
9.5 South Africa Enteric Disease Testing and Therapeutic Revenue and Growth Rate (2015-2020)
10 Market Size Segment by Type
10.1 Global Enteric Disease Testing and Therapeutic Revenue and Market Share by Type (2015-2020)
10.2 Global Enteric Disease Testing and Therapeutic Market Forecast by Type (2019-2024)
10.3 Bacterial disease Revenue Growth Rate (2015-2025)
10.4 Viral disease Revenue Growth Rate (2015-2025)
10.5 Parasitic diseases Revenue Growth Rate (2015-2025)
11 Global Enteric Disease Testing and Therapeutic Market Segment by Application
11.1 Global Enteric Disease Testing and Therapeutic Revenue Market Share by Application (2015-2020)
11.2 Enteric Disease Testing and Therapeutic Market Forecast by Application (2019-2024)
11.3 Hospital Revenue Growth (2015-2020)
11.4 Research Revenue Growth (2015-2020)
12 Global Enteric Disease Testing and Therapeutic Market Size Forecast (2021-2025)
12.1 Global Enteric Disease Testing and Therapeutic Market Size Forecast (2021-2025)
12.2 Global Enteric Disease Testing and Therapeutic Market Forecast by Regions (2021-2025)
12.3 North America Enteric Disease Testing and Therapeutic Revenue Market Forecast (2021-2025)
12.4 Europe Enteric Disease Testing and Therapeutic Revenue Market Forecast (2021-2025)
12.5 Asia-Pacific Enteric Disease Testing and Therapeutic Revenue Market Forecast (2021-2025)
12.6 South America Enteric Disease Testing and Therapeutic Revenue Market Forecast (2021-2025)
12.7 Middle East & Africa Enteric Disease Testing and Therapeutic Revenue Market Forecast (2021-2025)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
14.3 Disclaimer
14.4 About US
Table 1. Global Enteric Disease Testing and Therapeutic Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Enteric Disease Testing and Therapeutic by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Enteric Disease Testing and Therapeutic Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 4. Global Market Enteric Disease Testing and Therapeutic Revenue (Million USD) Comparison by Regions 2015-2025
Table 5. Abbott Corporate Information, Location and Competitors
Table 6. Abbott Enteric Disease Testing and Therapeutic Major Business
Table 7. Abbott Enteric Disease Testing and Therapeutic Total Revenue (USD Million) (2017-2018)
Table 8. Abbott SWOT Analysis
Table 9. Abbott Enteric Disease Testing and Therapeutic Product and Solutions
Table 10. Abbott Enteric Disease Testing and Therapeutic Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 11. Quest Diagnostics Corporate Information, Location and Competitors
Table 12. Quest Diagnostics Enteric Disease Testing and Therapeutic Major Business
Table 13. Quest Diagnostics Enteric Disease Testing and Therapeutic Total Revenue (USD Million) (2018-2019)
Table 14. Quest Diagnostics SWOT Analysis
Table 15. Quest Diagnostics Enteric Disease Testing and Therapeutic Product and Solutions
Table 16. Quest Diagnostics Enteric Disease Testing and Therapeutic Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 17. bioMérieux Corporate Information, Location and Competitors
Table 18. bioMérieux Enteric Disease Testing and Therapeutic Major Business
Table 19. bioMérieux Enteric Disease Testing and Therapeutic Total Revenue (USD Million) (2017-2018)
Table 20. bioMérieux SWOT Analysis
Table 21. bioMérieux Enteric Disease Testing and Therapeutic Product and Solutions
Table 22. bioMérieux Enteric Disease Testing and Therapeutic Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 23. GlaxoSmithKline Corporate Information, Location and Competitors
Table 24. GlaxoSmithKline Enteric Disease Testing and Therapeutic Major Business
Table 25. GlaxoSmithKline Enteric Disease Testing and Therapeutic Total Revenue (USD Million) (2017-2018)
Table 26. GlaxoSmithKline SWOT Analysis
Table 27. GlaxoSmithKline Enteric Disease Testing and Therapeutic Product and Solutions
Table 28. GlaxoSmithKline Enteric Disease Testing and Therapeutic Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 29. Bio-Rad Corporate Information, Location and Competitors
Table 30. Bio-Rad Enteric Disease Testing and Therapeutic Major Business
Table 31. Bio-Rad Enteric Disease Testing and Therapeutic Total Revenue (USD Million) (2017-2018)
Table 32. Bio-Rad SWOT Analysis
Table 33. Bio-Rad Enteric Disease Testing and Therapeutic Product and Solutions
Table 34. Bio-Rad Enteric Disease Testing and Therapeutic Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 35. Becton Dickinson Corporate Information, Location and Competitors
Table 36. Becton Dickinson Enteric Disease Testing and Therapeutic Major Business
Table 37. Becton Dickinson Enteric Disease Testing and Therapeutic Total Revenue (USD Million) (2017-2018)
Table 38. Becton Dickinson SWOT Analysis
Table 39. Becton Dickinson Enteric Disease Testing and Therapeutic Product and Solutions
Table 40. Becton Dickinson Enteric Disease Testing and Therapeutic Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 41. Bayer Pharma Corporate Information, Location and Competitors
Table 42. Bayer Pharma Enteric Disease Testing and Therapeutic Major Business
Table 43. Bayer Pharma Enteric Disease Testing and Therapeutic Total Revenue (USD Million) (2017-2018)
Table 44. Bayer Pharma SWOT Analysis
Table 45. Bayer Pharma Enteric Disease Testing and Therapeutic Product and Solutions
Table 46. Bayer Pharma Enteric Disease Testing and Therapeutic Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 47. Sanofi Corporate Information, Location and Competitors
Table 48. Sanofi Enteric Disease Testing and Therapeutic Major Business
Table 49. Sanofi Enteric Disease Testing and Therapeutic Total Revenue (USD Million) (2017-2018)
Table 50. Sanofi SWOT Analysis
Table 51. Sanofi Enteric Disease Testing and Therapeutic Product and Solutions
Table 52. Sanofi Enteric Disease Testing and Therapeutic Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 53. Trinity Biotech Corporate Information, Location and Competitors
Table 54. Trinity Biotech Enteric Disease Testing and Therapeutic Major Business
Table 55. Trinity Biotech Enteric Disease Testing and Therapeutic Total Revenue (USD Million) (2017-2018)
Table 56. Trinity Biotech SWOT Analysis
Table 57. Trinity Biotech Enteric Disease Testing and Therapeutic Product and Solutions
Table 58. Trinity Biotech Enteric Disease Testing and Therapeutic Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 59. Global Enteric Disease Testing and Therapeutic Revenue (Million USD) by Players (2015-2020)
Table 60. Global Enteric Disease Testing and Therapeutic Revenue Share by Players (2015-2020)
Table 61. Global Enteric Disease Testing and Therapeutic Revenue (Million USD) by Regions (2015-2020)
Table 62. Global Enteric Disease Testing and Therapeutic Revenue Market Share by Regions (2015-2020)
Table 63. North America Enteric Disease Testing and Therapeutic Revenue by Countries (2015-2020)
Table 64. North America Enteric Disease Testing and Therapeutic Revenue Market Share by Countries (2015-2020)
Table 65. Europe Enteric Disease Testing and Therapeutic Revenue (Million USD) by Countries (2015-2020)
Table 66. Asia-Pacific Enteric Disease Testing and Therapeutic Revenue (Million USD) by Countries (2015-2020)
Table 67. South America Enteric Disease Testing and Therapeutic Revenue by Countries (2015-2020)
Table 68. South America Enteric Disease Testing and Therapeutic Revenue Market Share by Countries (2015-2020)
Table 69. Middle East and Africa Enteric Disease Testing and Therapeutic Revenue (Million USD) by Countries (2015-2020)
Table 70. Middle East and Africa Enteric Disease Testing and Therapeutic Revenue Market Share by Countries (2015-2020)
Table 71. Global Enteric Disease Testing and Therapeutic Revenue (Million USD) by Type (2015-2020)
Table 72. Global Enteric Disease Testing and Therapeutic Revenue Share by Type (2015-2020)
Table 73. Global Enteric Disease Testing and Therapeutic Revenue Forecast by Type (2021-2025)
Table 74. Global Enteric Disease Testing and Therapeutic Revenue by Application (2015-2020)
Table 75. Global Enteric Disease Testing and Therapeutic Revenue Share by Application (2015-2020)
Table 76. Global Enteric Disease Testing and Therapeutic Revenue Forecast by Application (2021-2025)
Table 77. Global Enteric Disease Testing and Therapeutic Revenue (Million USD) Forecast by Regions (2021-2025)
List of Figures
Figure 1. Enteric Disease Testing and Therapeutic Picture
Figure 2. Global Enteric Disease Testing and Therapeutic Revenue Market Share by Type in 2019
Figure 3. Bacterial disease Picture
Figure 4. Viral disease Picture
Figure 5. Parasitic diseases Picture
Figure 6. Enteric Disease Testing and Therapeutic Revenue Market Share by Application in 2019
Figure 7. Hospital Picture
Figure 8. Research Picture
Figure 9. Global Enteric Disease Testing and Therapeutic Revenue (USD Million) and Growth Rate (2015-2025)
Figure 10. North America Enteric Disease Testing and Therapeutic Revenue (Million USD) and Growth Rate (2015-2025)
Figure 11. Europe Enteric Disease Testing and Therapeutic Revenue (Million USD) and Growth Rate (2015-2025)
Figure 12. Asia-Pacific Enteric Disease Testing and Therapeutic Revenue (Million USD) and Growth Rate (2015-2025)
Figure 13. South America Enteric Disease Testing and Therapeutic Revenue (Million USD) and Growth Rate (2015-2025)
Figure 14. Middle East and Africa Enteric Disease Testing and Therapeutic Revenue (Million USD) and Growth Rate (2015-2025)
Figure 15. Global Enteric Disease Testing and Therapeutic Revenue (Million USD) and Growth Rate (2015-2025)
Figure 16. Global Enteric Disease Testing and Therapeutic Revenue Share by Players in 2019
Figure 17. Global Top 5 Players Enteric Disease Testing and Therapeutic Revenue Market Share in 2019
Figure 18. Global Top 10 Players Enteric Disease Testing and Therapeutic Revenue Market Share in 2019
Figure 19. Key Players Market Share Trend
Figure 20. Global Enteric Disease Testing and Therapeutic Revenue (Million USD) and Growth Rate (%) (2015-2020)
Figure 21. Global Enteric Disease Testing and Therapeutic Revenue Market Share by Regions (2015-2020)
Figure 22. Global Enteric Disease Testing and Therapeutic Revenue Market Share by Regions in 2018
Figure 23. North America Enteric Disease Testing and Therapeutic Revenue and Growth Rate (2015-2020)
Figure 24. Europe Enteric Disease Testing and Therapeutic Revenue and Growth Rate (2015-2020)
Figure 25. Asia-Pacific Enteric Disease Testing and Therapeutic Revenue and Growth Rate (2015-2020)
Figure 26. South America Enteric Disease Testing and Therapeutic Revenue and Growth Rate (2015-2020)
Figure 27. Middle East and Africa Enteric Disease Testing and Therapeutic Revenue and Growth Rate (2015-2020)
Figure 28. North America Enteric Disease Testing and Therapeutic Revenue Market Share by Countries (2015-2020)
Figure 29. North America Enteric Disease Testing and Therapeutic Revenue Market Share by Countries in 2019
Figure 30. USA Enteric Disease Testing and Therapeutic Revenue and Growth Rate (2015-2020)
Figure 31. Canada Enteric Disease Testing and Therapeutic Revenue and Growth Rate (2015-2020)
Figure 32. Mexico Enteric Disease Testing and Therapeutic Revenue and Growth Rate (2015-2020)
Figure 33. Europe Enteric Disease Testing and Therapeutic Revenue Market Share by Countries (2015-2020)
Figure 34. Europe Enteric Disease Testing and Therapeutic Revenue Market Share by Countries in 2019
Figure 35. Germany Enteric Disease Testing and Therapeutic Revenue and Growth Rate (2015-2020)
Figure 36. UK Enteric Disease Testing and Therapeutic Revenue and Growth Rate (2015-2020)
Figure 37. France Enteric Disease Testing and Therapeutic Revenue and Growth Rate (2015-2020)
Figure 38. Russia Enteric Disease Testing and Therapeutic Revenue and Growth Rate (2015-2020)
Figure 39. Italy Enteric Disease Testing and Therapeutic Revenue and Growth Rate (2015-2020)
Figure 40. Asia-Pacific Enteric Disease Testing and Therapeutic Revenue Market Share by Countries (2015-2020)
Figure 41. Asia-Pacific Enteric Disease Testing and Therapeutic Revenue Market Share by Countries in 2019
Figure 42. China Enteric Disease Testing and Therapeutic Revenue and Growth Rate (2015-2020)
Figure 43. Japan Enteric Disease Testing and Therapeutic Revenue and Growth Rate (2015-2020)
Figure 44. Korea Enteric Disease Testing and Therapeutic Revenue and Growth Rate (2015-2020)
Figure 45. India Enteric Disease Testing and Therapeutic Revenue and Growth Rate (2015-2020)
Figure 46. Southeast Asia Enteric Disease Testing and Therapeutic Revenue and Growth Rate (2015-2020)
Figure 47. South America Enteric Disease Testing and Therapeutic Revenue Market Share by Countries (2015-2020)
Figure 48. South America Enteric Disease Testing and Therapeutic Revenue Market Share by Countries in 2019
Figure 49. Brazil Enteric Disease Testing and Therapeutic Revenue and Growth Rate (2015-2020)
Figure 50. Argentina Enteric Disease Testing and Therapeutic Revenue and Growth Rate (2015-2020)
Figure 51. Middle East and Africa Enteric Disease Testing and Therapeutic Revenue Market Share by Countries (2015-2020)
Figure 52. Middle East and Africa Enteric Disease Testing and Therapeutic Revenue Market Share by Countries in 2019
Figure 53. Saudi Arabia Enteric Disease Testing and Therapeutic Revenue and Growth Rate (2015-2020)
Figure 54. UAE Enteric Disease Testing and Therapeutic Revenue and Growth Rate (2015-2020)
Figure 55. Egypt Enteric Disease Testing and Therapeutic Revenue and Growth Rate (2015-2020)
Figure 56. South Africa Enteric Disease Testing and Therapeutic Revenue and Growth Rate (2015-2020)
Figure 57. Global Enteric Disease Testing and Therapeutic Revenue Share by Type (2015-2020)
Figure 58. Global Enteric Disease Testing and Therapeutic Revenue Share by Type in 2019
Figure 59. Global Enteric Disease Testing and Therapeutic Market Share Forecast by Type (2021-2025)
Figure 60. Global Bacterial disease Revenue Growth Rate (2015-2020)
Figure 61. Global Viral disease Revenue Growth Rate (2015-2020)
Figure 62. Global Parasitic diseases Revenue Growth Rate (2015-2020)
Figure 63. Global Enteric Disease Testing and Therapeutic Revenue Share by Application (2015-2020)
Figure 64. Global Enteric Disease Testing and Therapeutic Revenue Share by Application in 2019
Figure 65. Global Enteric Disease Testing and Therapeutic Market Share Forecast by Application (2021-2025)
Figure 66. Global Hospital Revenue Growth Rate (2015-2020)
Figure 67. Global Research Revenue Growth Rate (2015-2020)
Figure 68. Global Enteric Disease Testing and Therapeutic Revenue (Million USD) and Growth Rate Forecast (2021-2025)
Figure 69. Global Enteric Disease Testing and Therapeutic Revenue (Million USD) Forecast by Regions (2021-2025)
Figure 70. Global Enteric Disease Testing and Therapeutic Revenue Market Share Forecast by Regions (2021-2025)
Figure 71. North America Enteric Disease Testing and Therapeutic Revenue Market Forecast (2021-2025)
Figure 72. Europe Enteric Disease Testing and Therapeutic Revenue Market Forecast (2021-2025)
Figure 73. Asia-Pacific Enteric Disease Testing and Therapeutic Revenue Market Forecast (2021-2025)
Figure 74. South America Enteric Disease Testing and Therapeutic Revenue Market Forecast (2021-2025)
Figure 75. Middle East and Africa Enteric Disease Testing and Therapeutic Revenue Market Forecast (2021-2025)
Figure 76. Sales Channel: Direct Channel vs Indirect Channel
感染症用POC検査の世界市場 2020年：企業別、地域別、種類・用途別 Market Overview The global Point of Care Testing for Infectious Disease market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The …- 感染症検査における分子診断の世界市場 2020年：企業別、地域別、種類・用途別 Market Overview The global Molecular Diagnostics in Infectious Disease Testing market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 201…
- ポイントオブケア感染症診断/検査の世界市場 2020年：企業別、地域別、種類・用途別 Market Overview The global Point-of-Care Infectious Disease Diagnostics/Testing market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of 5.2% in the forecast period of 2020 to 2025 and will expected to reach USD 1257.8 million by 2025, from USD 1026.6 mill…
- 腸溶性ソフトジェルカプセルの世界市場 2020年：メーカー別、地域別、種類・用途別 Market Overview The global Enteric Softgel Capsules market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of 2.3% in the forecast period of 2020 to 2025 and will expected to reach USD 1872.2 million by 2025, from USD 1710.8 million in 2019. The Enteric Sof…
- 遺伝病診断の世界市場 2020年：企業別、地域別、種類・用途別 Market Overview The global Genetic Disease Diagnostic market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Genetic Disease Di…